Delivery Order SPE2DB24D2205-SPE2DB25FECVM
- Not listed
- The Defense Logistics Agency awarded a $33,133.71 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Wezlana 90 mg/ml syringes. This firm fixed price delivery order, with an ultimate completion date of September 15, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for supply of Wezlana 90 mg/ml syringes valued at $30,098.11. This non-set-aside, firm fixed-price delivery order represents a competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,540.76 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/mL syringes. This competitive delivery order, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, utilizes firm fixed pricing and carries no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a $12,511.19 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/ml syringes on September 23, 2025, with completion scheduled for September 24, 2025. This competitive award, which includes no set-aside designation, represents a child delivery order issued under AmerisourceBergen's broader indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $82,826.37 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/ml syringes, with an ultimate completion date of September 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on September 8, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,991.07 to AmerisourceBergen Drug Corp for Wezlana 90 mg/mL syringes. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for completion by September 29, 2025. The award was issued on September 26, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/ml syringes with a ceiling value of $13,396.25 under a firm fixed price contract type. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, and the work will be performed in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order that represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,735.28 to AmerisourceBergen Drug Corp for Wezlana 90 mg/ml syringes. This firm fixed-price delivery order, issued on August 5, 2025, represents a non-competitive award executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6,...
- The Defense Logistics Agency awarded a $20,125.87 delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Wezlana 90 mg/ml syringes. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by June 4, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $15,763.91 to AmerisourceBergen Drug Corp for Wezlana 90 mg/ml syringes, with a completion date of September 15, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The product will be delivered to the place of performance in Conshohocken, PA. This delivery order represents a task order under AmerisourceBergen's...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FECVMDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/mL syringes valued at $71,235.11. This non-competitive delivery order, issued on May 27, 2025, with an ultimate completion date of May 28, 2025, represents a firm fixed-price transaction for pharmaceutical delivery. The award was fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a prime contractor specializing in pharmaceutical and medical supply distribution to federal healthcare systems, AmerisourceBergen serves critical medical procurement needs for the Department of Defense, Defense Health Agency, and other government healthcare entities. The IDC vehicle provides comprehensive global pharmaceutical support across multiple therapeutic domains, enabling efficient fulfillment of individual delivery orders for medical commodities supporting military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $71.2k | 5/27/25 |